KHC
11
2
EXR
60
3
SO
57
2
AKAM
50
7
FTI
76
3
UA
59
14
ALLE
44
7
VNO
50
-9
WAT
53
6
AAL
53
-4
CRM
65
6
HBI
55
-4
DOW
34
4
SRE
66
3
BAX
30
4
NAVI
47
3
MDT
62
3
KMX
64
6
LRCX
45
6
OMC
61
6
KHC
11
2
EXR
60
3
SO
57
2
AKAM
50
7
FTI
76
3
UA
59
14
ALLE
44
7
VNO
50
-9
WAT
53
6
AAL
53
-4
CRM
65
6
HBI
55
-4
DOW
34
4
SRE
66
3
BAX
30
4
NAVI
47
3
MDT
62
3
KMX
64
6
LRCX
45
6
OMC
61
6
Financhill
Back

Sino Biopharmaceutical 10K Form

Sell
35

SBMFF
Sino Biopharmaceutical

Last Price:
0.42
Seasonality Move:
-0.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SBMFF News And Ratings

See the #1 stock for the next 7 days that we like better than SBMFF

SBMFF Financial Statistics

Sales & Book Value

Annual Sales: $3.7B
Cash Flow: $0
Price / Cash Flow: 11.19
Annual Sales: $0.25
Price / Book: 1.73

Profitability

EPS (TTM): 0.01700
Net Income (TTM): $568.57M
Gross Margin: $3B
Return on Equity: 10.53%
Return on Assets: 6.27%

Sino Biopharmaceutical Earnings Forecast

Key Sino Biopharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 25 years for SBMFF is 80.95%.
  • The Selling, General & Administrative Expenses for SBMFF have been equal to 42.24% of Gross Profit Margin.
  • The Research & Development expenses have been 16.81% of Revenue.
  • The Interest Expense is 21.24% of Operating Income.
  • The Net Earning history of SBMFF is 8.90% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 7 years.

Sino Biopharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SBMFF
Website: sinobiopharm.com

Debt

Debt-to-Equity Ratio: 0.29
Current Ratio: 1.15
Quick Ratio: 1.07

Price-to-Earnings

Trailing P/E Ratio: 24.16
Forward P/E Ratio: 0

SBMFF Technical Analysis vs Fundamental Analysis

Sell
35
Sino Biopharmaceutical (SBMFF) is a Sell

Is Sino Biopharmaceutical a Buy or a Sell?